After years of success on Wegovy, an Oakland patient faces relapse as California cuts Medi-Cal coverage for chronic obesity ...

Fresh Tri ®, the leading neuroscience-based behavior change company, today announced the results of a nationwide multi-site, ...

Raleigh Weight Loss Center warns of GLP-1 medication risks & offers safe, natural weight loss solutions focusing on ...

The evolving relationship between GLP-1 medications and protein consumption presents both challenges and opportunities for ...

A coalition of Hispanic health and public policy organizations is pushing for New Mexico’s Medicaid program to broaden its coverage of weight loss drugs as treatment for obesity. The policy change, ...

Cynthia Bailey detailed her weight loss experience by using a GLP-1 to lose 36 pounds in a year in addition to using a diet ...

Participants in the National Diabetes Prevention Program lifestyle change program (LCP) who used an iterative approach — changing one’s approach to a problem when encountering challenges — through an ...

A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial ...

Orforglipron's launch and Medicare/Medicaid eligibility will expand Eli Lilly's addressable market and offset price erosion.

Stimulant medications can make some people have a smaller appetite. If you take both a GLP⁠-1 and a stimulant, you might not feel the need to eat as much as you need to. That could cause you to lose ...

The generic versions of semaglutide are expected to be at least 50% cheaper— ₹5,000 for a weekly dose—than Ozempic in India .